Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$67.31 - $124.76 $346,242 - $641,765
5,144 New
5,144 $496,000
Q1 2022

May 06, 2022

SELL
$63.15 - $90.42 $442 - $632
-7 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$77.28 - $99.42 $540 - $695
7 New
7 $0

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Mach 1 Financial Group, LLC Portfolio

Follow Mach 1 Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mach 1 Financial Group, LLC with notifications on news.